[Assessment of breast implants, tissue expanders and external breast prostheses]
Haute Autorité de Santé
Record ID 32016000278
French
Authors' objectives:
The aim of this current project is to revise the categories "External breast prosthesis, breast implant, tissue expander".
In 2009, external non-solid silicone breast prostheses and external fluid-filled prostheses are reimbursed by the French national health insurance, with no indication specified. Just one type of adhesive silicone prosthesis is reimbursed following mastectomy (Amoena Contact, made by Amoena France).
Breast implants that are reimbursed are textured implants of any shape. Implants are reimbursed if the indication is breast reconstruction, with the exception of exclusively cosmetic procedures.
The types of tissue expanders that are reimbursed by the French national health insurance are either smooth, textured with integrated valve or textured with a self-closing valve.
Indications are stated for each class of tissue expander: in breast reconstruction for textured and smooth expanders, in plastic and reconstructive surgery under defined conditions for smooth expanders [significant loss of tissue (burns, trauma or following extensive excision of naevi or tumours) as an alternative to skin graft; congenital facial malformation, particularly in children].
Details
Project Status:
Completed
Year Published:
2009
URL for published report:
http://www.has-sante.fr/portail/upload/docs/application/pdf/2009-10/rapport_implants_mammaires.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
France
MeSH Terms
- Humans
- Breast
- Breast Implants
- Tissue Expansion Devices
- Breast Implantation
Contact
Organisation Name:
Haute Autorité de Santé
Contact Address:
2 avenue du Stade de France, 93218 Saint-Denis La Plaine Cedex, France. Tel: +33 01 55 93 71 88; Fax: +33 01 55 93 74 35;
Contact Name:
has.seap.secretariat@has-sante.fr
Contact Email:
has.seap.secretariat@has-sante.fr
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.